Biocidal Products: Regulation
The question
To ask the Secretary of State for Work and Pensions, what assessment the Health and Safety Executive has made of its proposals to replace expiry dates for biocidal active substance approvals with a mechanism to ‘call in’ these substances for review on (a) the safety of active substances on the market and (b) their impact on (i) health and (ii) the environment.
Answered by Sir Stephen Timms
The Health and Safety Executive's (HSE) legislative reforms aim to provide greater flexibility to the regulator while maintaining the current high standards offered by chemicals regulatory regimes, including the Great Britain Biocidal Products Regulation (GB BPR), to human health and the environment.
The proposal to remove fixed expiry dates and introduce a risk-based 'call-in' system for active substance reviews would permit HSE to focus evaluation work where it would have the greatest impact particularly on addressing initial assessments that are required as part of the GB Active Substance Review Programme. Active substances requiring initial evaluation will as yet have had no evaluation, consequently risks are much less well understood than active substances (biocidal approvals) that have already been thoroughly evaluated and deemed acceptable.
This proposed change of approach will enable HSE to continue to make efficient and effective regulatory decisions to address risks to people’s safety, health and the environment.
All decisions on these proposals are subject to an analysis of the consultation responses, which is currently underway, and all final decisions are subject to parliamentary scrutiny.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →